NCT04255849 2026-01-23
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Weill Medical College of Cornell University
Phase 3 Active not recruiting
Clinical Trials
6 trialsNCT04794660 2024-03-13
CESTA
International Agency for Research on Cancer
Phase 3 Active not recruiting
NCT05173324 2022-08-03
H2VICTORY
International Agency for Research on Cancer
Phase 3 Not yet recruiting
NCT02009800 2022-04-28
ICI-VPH
CHU de Quebec-Universite Laval
Phase 3 Completed
NCT02346227 2018-10-12
KINVAV
Universiteit Antwerpen
Phase 3 Completed
NCT01512784 2012-01-19
Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
University of Milan
Phase 3 Unknown